HAIRY CELL LEUKEMIA
Clinical trials for HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to control Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a daily pill called ibrutinib for people with hairy cell leukemia that has returned after previous treatment. The goal is to see if the drug can control the cancer by blocking a protein that helps the cancer cells grow. Researchers will measure how well pati…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Two-Drug attack on rare blood cancer shows promise
Disease control OngoingThis study is testing whether combining two drugs—an oral targeted therapy (vemurafenib) and an immunotherapy infusion (obinutuzumab)—can effectively treat adults with hairy cell leukemia who haven't had any prior treatment. The goal is to achieve a complete remission, meaning no…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC